by Philippe Marteau
Machiels et al. recently described that the composition of the faecal microbiota of patients suffering from ulcerative colitis differs from
by Andreu Prados
A new study, led by Dr. Lora Hooper from the University of Texas Southwestern Medical Center in Dallas (Texas, USA), has found that compositional changes in intestinal phage communities occur during colitis in mice.
Differences in the gut microbiota in patients with IBD compared to healthy controls suggest that probiotics may be of help. This article takes an in-depth look into the rationale of using probiotics for IBD and summarizes the evidence from recent clinical guidelines for the use of probiotics in Crohn’s disease, ulcerative colitis and pouchitis.
by Andreu Prados
Inflammatory bowel disease covers chronic inflammatory conditions of the gastrointestinal tract, such as Crohn’s disease and ulcerative colitis. Find out more about the typical and atypical forms of IBD and what science knows about how the gut microbiota is involved in its development.
by Cristina Sáez
A new study performed on mice by researchers from Spain and Canada has found that gut bacteria may play a role in protecting us from inflammatory bowel diseases (IBD) and specifically ulcerative colitis.
Inflammatory bowel disease (IBD) is a family of intestinal disorders including Crohn’s disease (CD) and ulcerative colitis (UC) that are characterized by chronic and recurring periods of severe colonic (UC) or intestinal (CD) inflammation and extraintestinal symptoms.
by Andreu Prados
Faecal microbiota transplantation has been demonstrated to be a safe and highly effective therapeutic option for refractory C. difficile infection (CDI), and many studies have shown that it may possibly have applications in other illnesses such as inflammatory bowel disease (IBD) and in particular for ulcerative colitis (UC).
by Andreu Prados
The occurrence of inflammatory bowel disease (IBD) -ulcerative colitis (UC) and Crohn’s disease (CD)- is increasing worldwide, yet the reasons remain unknown.
The year 2023 has been a productive year for gut microbiome research. Read about the most relevant advances in translational and clinical gut microbiome research from the last 12 months, selected by the Gut Microbiota for Health editorial team.
by Andreu Prados, Rene van den Wijngaard
NeuroGASTRO 2023, the leading meeting in Europe held by ESNM on the latest developments in neurogastroenterology, digestive motility, and disorders of gut-brain interaction, took place from August 31st to September 2nd, 2023. Find out more about the main takeaways from the role of fecal microbiota transplants, microbial consortia and probiotics in disorders of gut-brain interaction picked up by GMFH editors (Part 2).
